Skip to main content
DRUG logo
DRUG
(NASDAQ)
Bright Minds Biosciences Inc.
$71.46-- (--)
Loading... - Market loading

Bright Minds Biosciences (DRUG) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Bright Minds Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions CAD

Scroll to see more
Bright Minds Biosciences Inc. income statement - Annual data in millions CAD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep 2025Dec 2024Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.000.00
Cost of Revenue0.080.070.000.070.010.000.000.00
Gross Profit-0.08-0.070.00-0.07-0.010.000.000.00
Operating Expenses
Research & Development11.081.181.185.0012.186.310.350.04
Selling, General & Administrative2.571.441.452.202.552.290.110.04
Operating Expenses13.942.742.827.3914.738.600.470.08
Operating Income-13.94-2.81-2.82-7.39-14.73-8.76-0.47-0.08
Other Income/Expense
Interest Income1.520.030.030.000.000.000.000.00
Interest Expense-0.040.010.000.020.220.000.000.00
Other Income/Expense0.190.01-0.010.01-0.24-0.03-0.010.16
Income
Income Before Tax-12.23-2.80-2.80-7.37-14.96-8.65-0.48-0.08
Income Tax Expense0.000.000.000.000.22-0.140.010.00
Net Income-12.23-2.80-2.80-7.37-14.96-8.52-0.49-0.08
Net Income - Continuous Operations-12.23-2.80-2.80-7.37-15.19-8.52-0.49-0.08
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA-13.86-2.72-2.75-7.31-14.730.000.000.00
EBIT-13.940.00-2.82-7.39-14.73-8.620.000.00
Depreciation & Amortization0.080.070.070.070.018.620.470.24
Earnings Per Share
Basic EPS-2.00-1.00-1.00-2.00-6.00-5.00--
Diluted EPS-2.00-1.00-1.00-2.00-6.00-5.00--
Basic Shares Outstanding6.884.314.313.722.471.791.281.28
Diluted Shares Outstanding6.884.314.313.722.471.791.281.28

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.